GT316
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GT316, covering 2025-02-17 to 2025-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (gynecological Tumors) [NA]